Abstract
Recognition of the importance of programmed cell death in basic biological processes as well as its relevance to clinical problems has led to a surge of research interest in this area in recent years. The appealing idea behind much of this research is that an endogenous death pathway is present in most cells which can be triggered to kill cells by physiological signals or when they encounter some types of stressful conditions. In spite of the rapid progress made in some respects, fundamental issues in this field remain unresolved, and the major challenge is still to molecularly characterize this death pathway and understand the controls which lead to its activation. Recent research in a number of laboratories has identified a family of enzymes which at very least now provides a testable candidate for a central player in such physiological death pathways. Specific inhibitors of these enzymes are newly available tools which can be used to test for their participation in particular physiological and experimental cell death systems (Henkart, 1996). In this paper we will present examples illustrating their use from our own studies on lymphoid cells. For reasons which will become clear, we believe that a functional death criterion based on inhibiting enzyme function provides a more significant characterization of cell death than the commonly used apoptotic death phenotypes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alnemri, E.S., Livingston, DJ., Thornberry, N.A., Wong, W.W., and Yuan, J. (1996). Human ICE/CED-3 protease nomenclature. Cell 87, 171.
Armstrong, R.C., Aka, T., Xiang, J., Gaur, S., Krebs, J.F., Hoang, K., Bai, X., Korsmeyer, S.J., Karanewsky, D.S., Fritz, L.C., and Tomaselli, K.J. (1996). Fas-induced activation of the cell death-related protease CPP-32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J. Biol. Chem. 271, 16850–16855.
Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORTl/FADD-interacting protease, in Fas/APO-1 — and TNF receptor-induced cell death. Cell 85, 803–815.
Bump, N.J., Hackett, M., Hugunin, M., Seshagiri, S., Brady, K., Chen, P., Ferenz, C., Franklin, S., Ghayur, T., Li, P., et al. (1995). Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269, 1885–1888.
Cain, K., Inayat-Hussain, S.H., Couet, C., and Cohen, G.M. (1996). A cleavage-site-directed inhibitor of interleukin 1 β-converting enzyme-like proteases inhibits apoptosis in primary cultures of rat hepatocytes. Biochem. J. 314, 27–32.
Fearnhead, H.O., Dinsdale, D., and Cohen, G.M. (1995). An interleukin-1-beta converting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Lett. 375, 283–288.
Hay, B.A., Wolff, T., and Rubin, G.M. (1994). Expression of baculovirus p35 prevents cell death in Drosophila. Development 120, 2121–2129.
Hengartner, M.O. and Horvitz, H.R. (1994). Programmed cell death in Caenorhabditis elegans. Curr. Opin. Genet. Dev. 4, 581–586.
Henkart, P.A. (1994). Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules. Immunity 1, 343–346.
Henkart, P.A. (1996). ICE Family Proteases: Mediators of all apoptotic cell death? (Review). Immunity 4, 195–201.
Jacobson, M.D., Weil, M., and Raff, M.C. (1996). Role of Ced3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell Biol. 133, 1041–1051.
Lagasse, E. and Weissman, I.L. (1994). bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med. 179, 1047–1052.
Lennon, S.V., Martin, S.J., and Cotter, T.G. (1991). Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif. 24, 203–214.
Liles, WC., Kiener, P.A., Ledbetter, J.A., Aruffo, A., and Klebanoff, S.J. (1996). Differential expression of Fas (CD95) and Fas Ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184, 429–440.
Memon, S.A., Moreno, M.B., Petrak, D., and Zacharchuk, C.M. (1995a). Bcl-2 blocks glucocorticoid-but not Fasor activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155, 4644–4652.
Memon, S.A., Petrak, D., Moreno, M.B., and Zacharchuk, C.M. (1995b). A simple assay for examining the effect of transiently expressed genes on programmed cell death. J. Immunol. Methods 180, 15–24.
Meredith, J.E., Fazeli, B., and Schwartz, M.A. (1993). The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4, 953–961.
Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O’Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., Mann, M., Krammer, P.H., Peter, M.E., and Dixit, V.M. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell 85, 817–827.
Nakajima, H., Golstein, P., and Henkart, P.A. (1995). The target cell nucleus is not required for cell-mediated granzyme-or Fas-based cytotoxicity. J. Exp. Med. 181, 1905–1909.
Pronk, G.J., Ramer, K., Amiri, P., and Williams, L.T. (1996). Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271, 808–810.
Ray, C.A., Black, R.A., Kronheim, S.R., Greenstreet, T.A., Sleath, P.R., Salvesen, G.S., and Pickup, DJ. (1992). Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1B converting enzyme. Cell 69, 597–604.
Rouvier, E., Luciani, M.F., and Golstein, P. (1993). Fas involvement in Ca+2-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195–200.
Sarin, A., Wu, M.-L., and Henkart, P.A. (1996). Different ICE-family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J. Exp. Med. 184.
Segal, D.M. and Wunderlich, J.R. (1988). Targeting of Cytotoxic Cells with Heterocrosslinked Antibodies. Cancer Invest. 6, 83–92.
Shimizu, S., Eguchi, Y., Kamiike, W., Waguri, S., Uchiyama, Y., Matsuda, H., and Tsujimoto, Y. (1996). Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13, 21–29.
Strasser, A., Harris, A.W., Huang, D.C.S., Krammer, P.H., and Cory, S. (1995). Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136–6147.
Sugimoto, A., Friesen, P.D., and Rothman, J.H. (1994). Baculovirus p35 prevents developmentally programmed cell death and rescues a ced-9 mutant in the nematode Caenorhabditis elegans. EMBO J. 13, 2023–2028.
Tadakuma, T., Kizaki, H., Odaka, C., Kubota, R., Ishimura, Y, Yagita, H., and Okumura, K. (1990). CD4+CD8+ thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody. Eur. J. Immunol. 20, 779–784.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sarin, A., Ebnet, K., Zacharchuk, C.M., Henkart, P.A. (1997). Caspase Inhibitors as Molecular Probes of Cell Death. In: Shi, YB., Shi, Y., Xu, Y., Scott, D.W. (eds) Programmed Cell Death. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0072-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0072-2_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0074-6
Online ISBN: 978-1-4899-0072-2
eBook Packages: Springer Book Archive